Olympus Shares Slump on FDA Warning Letter on Six Facilities

Olympus Corp. shares tumbled the most since April 2025 after the U.S. FDA issued a warning letter to the Japanese medical device maker following inspections at six facilities. The regulatory action signals potential compliance issues, spooking investors and raising concerns about the company's manufacturing practices and future operations.